Search alternatives:
significant effect » significant impact (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), clinical areas (Expand Search)
effect decrease » effects decreased (Expand Search)
linear decrease » linear increase (Expand Search)
significant effect » significant impact (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), clinical areas (Expand Search)
effect decrease » effects decreased (Expand Search)
linear decrease » linear increase (Expand Search)
-
41
Antihypertensive treatment of 151 T2DM patients with hypertension at different subgroups.
Published 2025Subjects: -
42
-
43
-
44
-
45
-
46
-
47
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: “…demonstrate sustained effects…”
-
48
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: “…demonstrate sustained effects…”
-
49
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: “…demonstrate sustained effects…”
-
50
-
51
-
52
-
53
-
54
-
55
-
56
EF-24 treatment significantly reduces cell viability in leukemia cell lines.
Published 2025Subjects: -
57
-
58
-
59
-
60
RTs (in ms, bars) and ACC (in %, line) for the rebound effect, with 95% confidence interval.
Published 2024Subjects: